Interactive Treatment Navigation Tool
There is a constant search for new and better ways to treat breast cancer. Advances over the last few decades have increased survival and improved the quality of life for people living with breast cancer. Therapies now under study should continue this trend into the future.
Our commitment to research
|
| At Susan G. Komen®, we are committed to ending breast cancer forever by energizing science to find the cures and ensuring quality care for all people, everywhere. Our global research grants and scientific programs are essential driving forces for achieving this mission. Many of the world’s leaders in breast cancer research have been supported by Komen’s Research and Scientific Programs – including three Nobel Laureates. Komen’s funding has supported research that has resulted in a better understanding of breast cancer; earlier detection; personalized, less invasive treatments for what was once a “one-treatment-fits-all” disease; and improved survival rates. Learn more about the exciting research we are funding. |
Emerging areas in treatment
Perhaps the most promising new treatments are targeted therapies that, unlike many of today's standard treatments, attack only cancer cells and leave healthy cells alone. Such targeted therapies may help limit side effects and improve survival.
Learn about new therapies currently under study in the following sections:
Clinical trials
Research is ongoing to improve all areas of treatment for breast cancer. New therapies are being studied in clinical trials. The results of these studies will decide whether these therapies become part of standard care. After discussing the benefits and risks with your health care provider, we encourage you to consider joining clinical trials of new therapies.
BreastCancerTrials.org in collaboration with Susan G. Komen® offers a custom matching service that can help you find a clinical trial that fits your health needs. Learn more about this program.
Learn more about clinical trials.
Updated 05/23/13
